Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study.
Barriers
Conventional services
Hospital pharmacy
Mental health
Pharmacist
Pharmacy services
Psychiatric pharmaceutical services
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
09 Mar 2022
09 Mar 2022
Historique:
received:
22
09
2021
accepted:
23
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
12
3
2022
Statut:
epublish
Résumé
Psychiatric pharmaceutical care is the provision of pharmaceutical care services to patients with psychiatric related illnesses or disorders. Several studies have demonstrated the positive influence psychiatric pharmaceutical care on patients' clinical, humanistic and economic outcomes. This study aimed to examine the extent of psychiatric pharmaceutical care practice in a convenience sample of Malaysian government hospitals and the barriers to the provision of these services. An anonymous cross-sectional survey of registered pharmacists working at a convenience sample of government hospitals in Malaysia was undertaken from September 2019 to June 2020. Pharmacists frequently ensured the appropriateness of the dose (55%), dosage form (47%) and dosing schedule (48%) of the dispensed medications. Most pharmacists infrequently worked with patients and healthcare professionals to develop a pharmacotherapeutic regimen and a corresponding monitoring plan (28%). There was no statistically significant difference in the provision of pharmaceutical care services with respect to gender, age, years of practice, and professional board certification. However, the services offered were influenced by the respondent's education and pharmacy setting. The obstacles perceived by pharmacists included lack of time (89%), shortage of pharmacy staff (87%), the patients' inability to comprehend medical information (85%), insufficient demand and acceptance by patients (82%), the lack of official policies and standardised practice protocols (78%), inaccessibility to the patients' medical records (77%) and the lack of structured communication channels between pharmacists and physicians (75%), the pharmacists lack of knowledge/skills and confidence (78%) and insufficient recognition from physicians to the pharmacists' skills (76%). This is the first study to explore the extent and barriers of psychiatric pharmaceutical care in Malaysian hospitals; it highlighted the need for mobilising pharmacists to expand these services.
Sections du résumé
BACKGROUND
BACKGROUND
Psychiatric pharmaceutical care is the provision of pharmaceutical care services to patients with psychiatric related illnesses or disorders. Several studies have demonstrated the positive influence psychiatric pharmaceutical care on patients' clinical, humanistic and economic outcomes. This study aimed to examine the extent of psychiatric pharmaceutical care practice in a convenience sample of Malaysian government hospitals and the barriers to the provision of these services.
METHODS
METHODS
An anonymous cross-sectional survey of registered pharmacists working at a convenience sample of government hospitals in Malaysia was undertaken from September 2019 to June 2020.
RESULTS
RESULTS
Pharmacists frequently ensured the appropriateness of the dose (55%), dosage form (47%) and dosing schedule (48%) of the dispensed medications. Most pharmacists infrequently worked with patients and healthcare professionals to develop a pharmacotherapeutic regimen and a corresponding monitoring plan (28%). There was no statistically significant difference in the provision of pharmaceutical care services with respect to gender, age, years of practice, and professional board certification. However, the services offered were influenced by the respondent's education and pharmacy setting. The obstacles perceived by pharmacists included lack of time (89%), shortage of pharmacy staff (87%), the patients' inability to comprehend medical information (85%), insufficient demand and acceptance by patients (82%), the lack of official policies and standardised practice protocols (78%), inaccessibility to the patients' medical records (77%) and the lack of structured communication channels between pharmacists and physicians (75%), the pharmacists lack of knowledge/skills and confidence (78%) and insufficient recognition from physicians to the pharmacists' skills (76%).
CONCLUSIONS
CONCLUSIONS
This is the first study to explore the extent and barriers of psychiatric pharmaceutical care in Malaysian hospitals; it highlighted the need for mobilising pharmacists to expand these services.
Identifiants
pubmed: 35264175
doi: 10.1186/s12913-022-07681-4
pii: 10.1186/s12913-022-07681-4
pmc: PMC8905759
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
321Informations de copyright
© 2022. The Author(s).
Références
Ann Pharmacother. 2005 Feb;39(2):319-28
pubmed: 15632223
Am J Psychiatry. 2017 May 1;174(5):438-450
pubmed: 28135844
J Adv Nurs. 2009 Mar;65(3):534-43
pubmed: 19222651
Int J Clin Pharm. 2018 Oct;40(5):1144-1153
pubmed: 29627872
Int J Clin Pract. 2011 Sep;65(9):954-75
pubmed: 21849010
Curr Psychiatry Rep. 2019 Feb 7;21(2):10
pubmed: 30729322
Psychiatr Q. 1996 Fall;67(3):235-43
pubmed: 8829246
Pharmacotherapy. 2003 Dec;23(12):1634-44
pubmed: 14695043
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Am J Health Syst Pharm. 1996 Jul 15;53(14):1713-6
pubmed: 8827240
JAMA. 1997 Jan 22-29;277(4):301-6
pubmed: 9002492
Pharm Pract (Granada). 2016 Oct-Dec;14(4):836
pubmed: 28042356
Int J Clin Pharm. 2015 Jun;37(3):485-96
pubmed: 25733064
Aust N Z J Psychiatry. 2012 Aug;46(8):762-73
pubmed: 22689337
BMC Med. 2014 Oct 22;12:200
pubmed: 25604462
Int J Clin Pharm. 2016 Apr;38(2):330-43
pubmed: 26758716
Am J Pharm Educ. 2010 Nov 10;74(9):163
pubmed: 21301597
J Eval Clin Pract. 2015 Feb;21(1):51-6
pubmed: 25041043
Aust N Z J Psychiatry. 2012 Aug;46(8):735-52
pubmed: 22696547
BMJ. 1999 Sep 4;319(7210):612-5
pubmed: 10473477
J Pharm Health Care Sci. 2019 Jan 10;5:1
pubmed: 30652009
Am J Geriatr Psychiatry. 2008 Aug;16(8):621-32
pubmed: 18669940
Bull World Health Organ. 1994;72(3):429-45
pubmed: 8062401
J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9
pubmed: 11297331
Am J Psychiatry. 1995 Dec;152(12):1749-56
pubmed: 8526241
Lancet. 2017 Sep 16;390(10100):1084-1150
pubmed: 28919115
PLoS One. 2009;4(2):e4439
pubmed: 19209224
Pharm Pract (Granada). 2010 Apr;8(2):122-31
pubmed: 25132880
Clin Drug Investig. 2006;26(7):415-25
pubmed: 17163274
Soc Psychiatry Psychiatr Epidemiol. 2010 Nov;45(11):1071-9
pubmed: 19826745
Am J Pharm Educ. 2008 Dec 15;72(6):133
pubmed: 19325953
Am J Hosp Pharm. 1990 Mar;47(3):533-43
pubmed: 2316538
Pharm Pract (Granada). 2016 Apr-Jun;14(2):680
pubmed: 27382419
Am J Health Syst Pharm. 2003 Apr 1;60(7):657-65
pubmed: 12701547
J Oncol Pharm Pract. 2017 Apr;23(3):185-194
pubmed: 26854267
Int J Clin Pharm. 2016 Apr;38(2):271-9
pubmed: 26739130
Healthcare (Basel). 2020 May 25;8(2):
pubmed: 32466229
Trop Med Int Health. 2008 Oct;13(10):1225-34
pubmed: 18937743
Int J Clin Pharm. 2014 Apr;36(2):222-32
pubmed: 24306436
Eur J Hosp Pharm. 2016 Nov;23(6):314-319
pubmed: 31156874
Pharmacotherapy. 1996 Jul-Aug;16(4):708-14
pubmed: 8840383